212 related articles for article (PubMed ID: 18046109)
1. The efficacy and safety of initial use of irbesartan/hydrochlorothiazide fixed-dose combination in hypertensive patients with and without high cardiovascular risk.
Weir MR; Neutel JM; Bhaumik A; De Obaldia ME; Lapuerta P
J Clin Hypertens (Greenwich); 2007 Dec; 9(12 Suppl 5):23-30. PubMed ID: 18046109
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
Lewin AJ; Weir MR
Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
Chrysant SG; Neutel JM; Ferdinand KC;
J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of irbesartan/HCTZ in severe hypertension according to cardiometabolic factors.
Franklin SS; Neutel JM
J Clin Hypertens (Greenwich); 2010 Jul; 12(7):487-94. PubMed ID: 20629810
[TBL] [Abstract][Full Text] [Related]
5. Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension.
Bramlage P
Vasc Health Risk Manag; 2009; 5(1):213-24. PubMed ID: 19436667
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
Sowers JR; Neutel JM; Saunders E; Bakris GL; Cushman WC; Ferdinand KC; Ofili EO; Weber MA;
J Clin Hypertens (Greenwich); 2006 Jul; 8(7):470-80. PubMed ID: 16849900
[TBL] [Abstract][Full Text] [Related]
7. Significance of initial blood pressure and comorbidity for the efficacy of a fixed combination of an angiotensin receptor blocker and hydrochlorothiazide in clinical practice.
Schmieder RE; Schwertfeger M; Bramlage P
Vasc Health Risk Manag; 2009; 5():991-1000. PubMed ID: 19997579
[TBL] [Abstract][Full Text] [Related]
8. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
Neutel JM
Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
[TBL] [Abstract][Full Text] [Related]
10. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
Rosenstock J; Rossi L; Lin CS; MacNeil D; Osbakken M
J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapy.
Cushman WC; Neutel JM; Saunders E; Bakris GL; Ferdinand KC; Ofili EO; Sowers JR; Madder R; Weber MA
Am J Geriatr Cardiol; 2008; 17(1):27-36. PubMed ID: 18174757
[TBL] [Abstract][Full Text] [Related]
12. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
Raskin P; Guthrie R; Flack J; Reeves R; Saini R
J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
[TBL] [Abstract][Full Text] [Related]
13. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
[TBL] [Abstract][Full Text] [Related]
14. Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy.
Franklin S; Lapuerta P; Cox D; Donovan M
J Clin Hypertens (Greenwich); 2007 Dec; 9(12 Suppl 5):15-22. PubMed ID: 18046108
[TBL] [Abstract][Full Text] [Related]
15. [The control rate of irbesartan/hydrochlorothiazide combination regimen in the treatment of Chinese patients with mild to moderate hypertension].
Sun NL; Jing S; Chen J
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):618-21. PubMed ID: 16080809
[TBL] [Abstract][Full Text] [Related]
16. [IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting].
Lehnert H; Bramlage P; Pittrow D; Kirch W
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():81-7. PubMed ID: 15490772
[TBL] [Abstract][Full Text] [Related]
17. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
Oparil S; Guthrie R; Lewin AJ; Marbury T; Reilly K; Triscari J; Witcher JA
Clin Ther; 1998; 20(3):398-409. PubMed ID: 9663357
[TBL] [Abstract][Full Text] [Related]
18. [Microalbuminuria in patients with hypertension and cardiovascular comorbidity, REAL observational study of treatment with Irbesartan/HCTZ].
Tschöpe C; Tschöpe R; Unger T
MMW Fortschr Med; 2006 Jun; 148(25):48. PubMed ID: 16859162
[No Abstract] [Full Text] [Related]
19. BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.
Schrader J; Bramlage P; Lüders S; Thoenes M; Schirmer A; Paar DW
Clin Drug Investig; 2007; 27(11):783-96. PubMed ID: 17914897
[TBL] [Abstract][Full Text] [Related]
20. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.
Kochar M; Guthrie R; Triscari J; Kassler-Taub K; Reeves RA
Am J Hypertens; 1999 Aug; 12(8 Pt 1):797-805. PubMed ID: 10480473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
